As of Feb 10
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 6.02, with a high estimate of 6.69 and a low estimate of 5.35. The median estimate represents a +14.00% increase from the last price of 5.28.
The current consensus among 2 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.